Related Experiment Videos
Sexually transmitted diseases: United States, 1995
Statistical Bulletin (Metropolitan Life Insurance Company : 1984)
|April 1, 1997
Summary
Sexually transmitted disease (STD) rates have shifted, with syphilis and gonorrhea declining significantly while chlamydial infections rise. STDs disproportionately impact vulnerable populations, increasing risks for serious health complications and HIV.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Over the last two decades, the US has seen significant shifts in sexually transmitted disease (STD) prevalence.
- Classic STDs like syphilis and gonorrhea have experienced notable rate changes, alongside the emergence of new pathogens.
Purpose of the Study:
- To analyze trends in rates of primary and secondary syphilis, gonorrhea, and chlamydial infections in the United States.
- To identify demographic and geographic patterns of these STDs.
- To highlight the health consequences and risk factors associated with STDs.
Main Methods:
- Analysis of national STD surveillance data over a 20-year period.
- Examination of trends in primary and secondary syphilis, gonorrhea, and chlamydial infection rates.
- Assessment of disease concentration in specific geographic regions and demographic groups.
Main Results:
- Primary and secondary syphilis rates decreased by 69% from a 1990 peak, reaching a 35-year low.
- Gonorrhea rates declined to a 30-year low by 1995.
- Chlamydial infections increased by over 55% since 1984 due to improved screening and reporting, with a higher incidence in women.
- Syphilis and gonorrhea are concentrated in southern states, while chlamydia is more geographically widespread.
- STDs disproportionately affect impoverished, inner-city, and minority populations.
Conclusions:
- Significant declines in syphilis and gonorrhea contrast with a rise in chlamydial infections.
- STDs continue to disproportionately affect vulnerable populations, leading to severe health consequences including sterility, ectopic pregnancy, fetal death, blindness, and increased HIV risk.